Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 11:59AM ET
16.65
Dollar change
-0.01
Percentage change
-0.09
%
IndexRUT P/E- EPS (ttm)-2.36 Insider Own14.20% Shs Outstand55.71M Perf Week4.42%
Market Cap927.29M Forward P/E- EPS next Y-3.62 Insider Trans-3.56% Shs Float47.80M Perf Month39.64%
Income-119.63M PEG- EPS next Q-0.83 Inst Own98.64% Short Float / Ratio12.87% / 3.30 Perf Quarter-66.46%
Sales0.00M P/S- EPS this Y2.50% Inst Trans26.33% Short Interest6.15M Perf Half Y-63.11%
Book/sh10.47 P/B1.59 EPS next Y-29.29% ROA-23.58% Target Price42.88 Perf Year-63.67%
Cash/sh9.96 P/C1.67 EPS next 5Y-14.60% ROE-25.82% 52W Range11.25 - 58.38 Perf YTD-69.63%
Dividend- P/FCF- EPS past 5Y- ROI-19.72% 52W High-71.49% Beta-0.52
Dividend %- Quick Ratio20.25 Sales past 5Y0.00% Gross Margin- 52W Low47.96% ATR1.17
Employees38 Current Ratio20.25 Sales Q/Q- Oper. Margin0.00% RSI (14)46.18 Volatility5.10% 6.65%
OptionableYes Debt/Eq0.04 EPS Q/Q22.43% Profit Margin- Rel Volume0.25 Prev Close16.66
ShortableYes LT Debt/Eq0.04 EarningsNov 13 BMO Payout- Avg Volume1.87M Price16.65
Recom1.00 SMA2010.04% SMA50-29.50% SMA200-58.27% Volume194,096 Change-0.09%
Date Action Analyst Rating Change Price Target Change
Sep-19-23Initiated Cantor Fitzgerald Overweight $69
Aug-28-23Initiated UBS Buy $83
Jan-27-23Upgrade Morgan Stanley Equal-Weight → Overweight $40 → $65
Sep-14-22Upgrade Evercore ISI In-line → Outperform $10 → $50
Oct-19-21Downgrade Morgan Stanley Overweight → Equal-Weight $27
Sep-10-21Initiated BofA Securities Buy $40
Feb-26-21Initiated Guggenheim Buy $54
Sep-10-20Initiated Morgan Stanley Overweight $70
Jul-20-20Reiterated H.C. Wainwright Buy $45 → $62
Jul-07-20Initiated Chardan Capital Markets Buy $79
Nov-14-23 07:21PM
Nov-13-23 07:00AM
Nov-10-23 08:57AM
Nov-08-23 07:00AM
Oct-17-23 04:05PM
04:38PM Loading…
Oct-12-23 04:38PM
08:24AM
Oct-11-23 05:35PM
11:11AM
Oct-10-23 04:13PM
04:03PM
12:10PM
11:44AM
10:37AM
09:29AM
07:15AM Loading…
07:15AM
07:00AM
Oct-09-23 04:05PM
Oct-05-23 07:01AM
Oct-04-23 08:00AM
Sep-29-23 12:43PM
Sep-27-23 09:24PM
Sep-14-23 07:56AM
Aug-31-23 07:00AM
Aug-28-23 07:00AM
Aug-11-23 06:00AM
Jul-11-23 09:02AM
Jul-10-23 09:32AM
09:29AM
08:58AM
08:00AM Loading…
Jul-07-23 08:00AM
07:46AM
Jul-03-23 11:20AM
10:25AM
Jul-01-23 09:00AM
Jun-29-23 10:04AM
09:59AM
09:18AM
Jun-28-23 10:53AM
Jun-27-23 01:47PM
Jun-26-23 11:23AM
11:15AM
10:36AM
08:50AM
08:21AM
06:41AM
Jun-23-23 10:50AM
09:15AM
07:00AM
Jun-22-23 09:18AM
Jun-21-23 03:21PM
10:46AM
Jun-20-23 08:54AM
Jun-19-23 10:28AM
10:18AM
Jun-16-23 10:26AM
08:39AM
Jun-15-23 09:43AM
08:18AM
Jun-14-23 12:17PM
11:48AM
09:26AM
Jun-13-23 10:14AM
09:40AM
09:18AM
Jun-12-23 10:00AM
09:48AM
Jun-08-23 11:49AM
11:20AM
Jun-07-23 12:31PM
08:50AM
Jun-06-23 01:13PM
12:13PM
11:14AM
Jun-05-23 12:43PM
11:40AM
10:22AM
07:39AM
07:14AM
07:00AM
Jun-02-23 11:36AM
07:12AM
Jun-01-23 04:05PM
May-31-23 10:46AM
08:00AM
May-30-23 10:56AM
May-29-23 07:48AM
May-26-23 10:51AM
May-24-23 08:14AM
May-23-23 09:55AM
May-17-23 01:59PM
May-16-23 06:53PM
06:33AM
May-15-23 07:00AM
May-10-23 08:50AM
May-04-23 09:21AM
06:26AM
Apr-18-23 09:55AM
Mar-29-23 04:01PM
Mar-22-23 04:09PM
Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young JonathanChief Operating OfficerNov 17Sale14.6830,000440,259153,177Nov 21 05:30 PM
Cheng AndrewPresident and CEOOct 02Option Exercise6.3625,000159,000485,998Oct 04 08:41 PM
Young JonathanChief Operating OfficerOct 02Option Exercise21.1049010,339183,667Oct 04 08:33 PM
Cheng AndrewPresident and CEOOct 02Sale47.9125,0001,197,827460,998Oct 04 08:41 PM
Young JonathanChief Operating OfficerOct 02Sale51.1049025,039183,177Oct 04 08:33 PM
Yale CatrionaChief Development OfficerSep 21Option Exercise6.365,00031,80051,010Sep 25 08:31 PM
Yale CatrionaChief Development OfficerSep 21Sale48.075,000240,35646,010Sep 25 08:31 PM
Graham G. WalmsleyDirectorSep 19Buy26.00400,00010,400,000400,000May 23 09:55 PM
Cheng AndrewPresident and CEOSep 13Sale50.341,68284,672460,998Sep 25 08:36 PM
White William RichardChief Financial OfficerSep 13Sale50.3463231,81518,468Sep 25 08:31 PM
Yale CatrionaChief Development OfficerSep 13Sale50.3461731,06046,010Sep 25 08:31 PM
Young JonathanChief Operating OfficerSep 13Sale50.3456228,291183,177Sep 25 08:28 PM
Rolph TimothyChief Scientific OfficerSep 13Sale50.3453126,731150,689Sep 25 08:30 PM
Cheng AndrewPresident and CEOSep 01Option Exercise6.3625,000159,000487,680Sep 18 06:48 PM
Cheng AndrewPresident and CEOSep 01Sale49.7725,0001,244,248462,680Sep 18 06:48 PM
Cheng AndrewPresident and CEOAug 30Option Exercise0.6115,0009,225462,680Aug 30 07:04 PM
Yale CatrionaChief Development OfficerAug 28Option Exercise6.365,74536,53852,372Aug 30 07:04 PM
Yale CatrionaChief Development OfficerAug 28Sale49.995,745287,19146,627Aug 30 07:04 PM
Graham G. WalmsleyDirectorAug 08Buy42.0625,0001,051,475600,000Aug 10 04:46 PM
Cheng AndrewPresident and CEOAug 01Option Exercise6.3625,000159,000472,680Aug 03 04:13 PM
Graham G. WalmsleyDirectorAug 01Buy43.2625,0001,081,525575,000Aug 01 07:52 PM
Cheng AndrewPresident and CEOAug 01Sale43.1525,0001,078,867447,680Aug 03 04:13 PM
Graham G. WalmsleyDirectorJul 28Buy42.6930,0001,280,709550,000Aug 01 07:52 PM
Cheng AndrewPresident and CEOJul 03Option Exercise6.3625,000159,000472,680Jul 06 08:44 PM
Cheng AndrewPresident and CEOJul 03Sale44.8825,0001,122,041447,680Jul 06 08:44 PM
Cheng AndrewPresident and CEOJun 27Option Exercise0.6140,00024,600447,680Jun 27 07:12 PM
Yale CatrionaChief Development OfficerJun 23Sale50.7611,000558,36046,627Jun 23 08:06 PM
Yale CatrionaChief Development OfficerJun 22Sale52.1811,000573,93557,627Jun 23 08:06 PM
Yale CatrionaChief Development OfficerJun 21Sale52.2611,349593,09568,627Jun 23 08:06 PM
White William RichardChief Financial OfficerJun 20Option Exercise7.0117,500122,65839,877Jun 22 05:20 PM
White William RichardChief Financial OfficerJun 20Sale55.0020,7771,142,73519,100Jun 22 05:20 PM
Heyman Tomas J.DirectorJun 16Option Exercise25.0426,000651,04026,000Jun 21 05:54 PM
Henderson JaneDirectorJun 16Option Exercise7.0140,000280,40040,000Jun 21 05:47 PM
Rolph TimothyChief Scientific OfficerJun 16Option Exercise0.6140,00024,400229,420Jun 21 05:46 PM
Rolph TimothyChief Scientific OfficerJun 16Sale54.7878,2004,284,066151,220Jun 21 05:46 PM
Henderson JaneDirectorJun 16Sale54.1740,0002,166,6850Jun 21 05:47 PM
Heyman Tomas J.DirectorJun 16Sale54.6726,0001,421,5290Jun 21 05:54 PM
Cheng AndrewPresident & CEOJun 13Sale55.161,61388,973407,680Jun 15 09:38 PM
White William RichardChief Financial OfficerJun 13Sale55.1660633,42722,377Jun 15 09:41 PM
Yale CatrionaChief Development OfficerJun 13Sale55.1659132,60079,976Jun 15 09:29 PM
Young JonathanChief Operating OfficerJun 13Sale55.1653829,676183,739Jun 15 09:35 PM
Rolph TimothyChief Scientific OfficerJun 13Sale55.1650928,076189,420Jun 15 09:35 PM
Cheng AndrewPresident and CEOJun 01Option Exercise1.4625,00036,459434,293Jun 05 06:23 PM
Cheng AndrewPresident and CEOJun 01Sale45.1025,0001,127,430409,293Jun 05 06:23 PM
Graham G. WalmsleyDirectorMay 19Buy42.00120,0005,040,000520,000May 23 09:55 PM
Cheng AndrewPresident & CEOMay 01Option Exercise0.6125,00015,375434,293May 03 08:28 PM
Cheng AndrewPresident & CEOMay 01Sale45.0725,0001,126,860409,293May 03 08:28 PM
Cheng AndrewPresident & CEOApr 18Option Exercise0.6140,00024,600409,293May 03 08:28 PM
Cheng AndrewPresident & CEOApr 03Option Exercise0.6125,00015,375394,293Apr 05 04:55 PM
Cheng AndrewPresident & CEOApr 03Sale37.9425,000948,576369,293Apr 05 04:55 PM
Cheng AndrewPresident & CEOMar 01Option Exercise0.6125,00015,375395,999Mar 03 04:21 PM
Cheng AndrewPresident & CEOMar 01Sale46.6525,0001,166,338370,999Mar 03 04:21 PM
Cheng AndrewPresident & CEOFeb 01Option Exercise0.6125,00015,375395,999Feb 03 05:25 PM
Cheng AndrewPresident & CEOFeb 01Sale49.0625,0001,226,395370,999Feb 03 05:25 PM
Yale CatrionaChief Development OfficerJan 13Sale50.535,000252,65181,268Jan 18 05:30 PM
Cheng AndrewPresident & CEOJan 03Option Exercise0.6125,00015,375395,999Jan 05 06:46 PM
Young JonathanChief Operating OfficerJan 03Option Exercise0.618,7775,398193,688Jan 05 05:56 PM
Cheng AndrewPresident & CEOJan 03Sale51.2725,0001,281,751370,999Jan 05 06:46 PM
Young JonathanChief Operating OfficerJan 03Sale54.648,777479,560184,911Jan 05 05:56 PM
Rolph TimothyChief Scientific OfficerDec 29Option Exercise28.357,816221,584210,848Dec 30 04:26 PM
Rolph TimothyChief Scientific OfficerDec 29Sale51.0520,3161,037,119190,532Dec 30 04:26 PM
Rolph TimothyChief Scientific OfficerDec 28Option Exercise28.351,70048,195204,732Dec 30 04:26 PM
White William RichardChief Financial OfficerDec 28Option Exercise7.019997,00224,623Dec 29 05:41 PM
Rolph TimothyChief Scientific OfficerDec 28Sale50.001,70085,006203,032Dec 30 04:26 PM
White William RichardChief Financial OfficerDec 28Sale49.7699949,71423,624Dec 29 05:41 PM
White William RichardChief Financial OfficerDec 27Option Exercise7.0119,001133,17842,625Dec 29 05:41 PM
Young JonathanChief Operating OfficerDec 27Option Exercise6.0312,50075,352194,949Dec 28 06:30 PM
White William RichardChief Financial OfficerDec 27Sale49.7719,001945,60923,624Dec 29 05:41 PM
Young JonathanChief Operating OfficerDec 27Sale49.5712,500619,609182,449Dec 28 06:30 PM
Cheng AndrewPresident & CEODec 16Option Exercise0.618,5005,228370,999Dec 20 07:46 PM
Yale CatrionaChief Development OfficerDec 12Sale43.235,000216,13786,268Dec 13 08:24 PM
Cheng AndrewPresident & CEODec 01Option Exercise0.6110,0006,150320,148Dec 02 05:52 PM
Skorpios TrustFormer 10% ownerDec 01Sale43.501,636,00071,166,0003,271,829Dec 05 04:36 PM
Cheng AndrewPresident & CEODec 01Sale46.0710,000460,700310,148Dec 02 05:52 PM